It is my pleasure to welcome you to the Tufts Center for the Study of Drug Development website.
I invite you to browse and learn more about our research activities, publications, professional development courses, forums, and information services.
Since 1976, we have provided scholarly assessments of the time, cost, and risk of new drug development, and we have consistently advocated on behalf of initiatives that further the cause of pharmaceutical innovation. Today, we remain the only multidisciplinary, academic research group committed to addressing the economic, scientific, political, and legal factors that influence the development, regulation, and utilization of new drugs and biologics.
Because of our reputation for scholarly and objective analyses of critical issues impacting the nature and pace of drug development, we are frequently asked to provide public testimony at U.S. Congressional and state-level hearings, interact with foreign government health agencies, prepare executive reports, and speak at conferences and public forums.
The challenges of developing a new pharmaceutical product and bringing it to market are increasing dramatically. The introduction of new tools and technologies offer significant opportunities for drug developers, but adoption of those technologies is often difficult and slow. Going forward, all stakeholders involved in new medicines development – pharmaceutical and biotechnology companies, regulators, policy-makers, academic research centers, technology companies, investors, contract service providers, and other organizations working with the research-based industry – will need to better understand the myriad factors that affect new product development.
We assist by:
Delivering the most complete, objective research on key drug development issues.
Offering university and postgraduate-level professional development programs on mission-critical topics.
Engaging in custom research projects, on an exclusive or syndicated basis.
If you have any questions, please feel free to contact us via email at email@example.com or phone at 617-636-2170.
Kenneth I Kaitin, PhD
Professor and Director